Almost 4.95 million deaths were associated with bacterial antimicrobial resistance (AMR) in 2019, and it’s a growing concern. As such, there is an urgent need to break down the AMR cycle between humans, the environment, and animals, as well as a call for alternative antibacterial agents. MHCombiotic Inc. (MHC) has formulated novel components with high antibacterial and anti-biofilm potency while also containing antioxidant and anti-inflammation properties to address this worldwide affliction.